| 前收市價 | 12.65 |
| 開市 | 12.65 |
| 買盤 | 12.13 x 無 |
| 賣出價 | 12.19 x 無 |
| 今日波幅 | 12.65 - 12.65 |
| 52 週波幅 | 7.58 - 15.16 |
| 成交量 | |
| 平均成交量 | 0 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
- Reuters
UPDATE 1-Elanco appoints two directors after settling with activist Ancora
Elanco Animal Health said on Monday that it had appointed two new directors to its board after reaching an agreement with activist investor Ancora Holdings but stopped short of naming a new CEO. The company that makes medicines and vaccinations for pets and livestock said it has added Kathy Turner and Craig Wallace to the board of directors. that it wanted four board seats at Elanco and to replace CEO Jeffrey Simmons over "poor performance."
- Reuters
Activist investor Ancora secures two Elanco board seats, Bloomberg News reports
Investment firm Ancora Holdings has reached an agreement with Elanco Animal Health to add two of its director candidates to the company's board, Bloomberg News reported late on Sunday, citing people with knowledge of the matter. Elanco, which makes medicines and vaccinations for pets and livestock will add Ancora nominees Craig Wallace and Kathy Turner to its board of directors, the report said. However, Elanco CEO Jeff Simmons will retain his position, the report added.
- Reuters
UPDATE 1-Ancora seeks four board seats at Elanco amid push for changes
Investment firm Ancora Holdings said it is pushing for four board seats at Elanco Animal Health and wants to replace the chief executive at the company that makes medicines and vaccinations for pets and livestock. Ancora nominated the director candidates, including one of the firm's executives, to Elanco's 12-person board and wants to oust CEO Jeffrey Simmons over what the activist investor calls poor performance. Elanco, which was spun out of pharmaceutical company Eli Lilly, is one of the world's leading developers and makers of animal health products and has a market value of $7.8 billion.
